Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.8839
-0.0145 (-1.61%)
Oct 30, 2026, 9:46 AM EDT - Market open
Coherus Oncology Employees
Coherus Oncology had 144 employees as of June 30, 2026. The number of employees decreased by 33 or 18.64% compared to the same quarter last year. That makes Coherus Oncology the 29,124th largest employer in the world and 3,696th in the United States.
Employees
144
Change (1Y)
-33
Growth (1Y)
-18.64%
Revenue / Employee
$353,722
Profits / Employee
-$917,583
Market Cap
136.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 144 | -33 | -18.64% |
| Mar 31, 2026 | 145 | -76 | -34.39% |
| Dec 31, 2025 | 147 | -81 | -35.53% |
| Sep 30, 2025 | 158 | -77 | -32.77% |
| Jun 30, 2025 | 177 | -69 | -28.05% |
| Mar 31, 2025 | 221 | -28 | -11.24% |
| Dec 31, 2024 | 228 | -78 | -25.49% |
| Sep 30, 2024 | 235 | -64 | -21.40% |
| Jun 30, 2024 | 246 | -48 | -16.33% |
| Mar 31, 2024 | 249 | -58 | -18.89% |
| Dec 31, 2023 | 306 | -53 | -14.76% |
| Sep 30, 2023 | 299 | -77 | -20.48% |
| Jun 30, 2023 | 294 | -74 | -20.11% |
| Mar 31, 2023 | 307 | -39 | -11.27% |
| Dec 31, 2022 | 359 | 27 | 8.13% |
| Sep 30, 2022 | 376 | 42 | 12.57% |
| Jun 30, 2022 | 368 | 57 | 18.33% |
| Mar 31, 2022 | 346 | 36 | 11.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Innate Pharma | 120 |
| Compass Therapeutics | 39 |
| NovaBridge Biosciences | 30 |
| Spruce Biosciences | 22 |
| TuHURA Biosciences | 22 |
CHRS News
- 1 day ago - Coherus Oncology assumed with a Buy at H.C. Wainwright - TheFly
- 1 day ago - Coherus Oncology announces clinical data from TREGCHECK development program - TheFly
- 1 day ago - Coherus Oncology Transcript: Study result - Transcripts
- 1 day ago - Coherus Oncology Press release: Study result - Filings
- 1 day ago - Coherus Oncology Slides: Study result - Filings
- 1 day ago - Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development - GlobeNewsWire
- 3 days ago - Coherus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 days ago - Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026 - GlobeNewsWire